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Introduction
After leaving the testis, mammalian spermatozoa are
morphologically differentiated but are immotile and unable to
fertilize. Progressive motility is acquired during epididymal
transit and fertilization capacity is gained while sperm traverse
the female reproductive tract in a process called capacitation.
Capacitation involves several changes, occurring in both the
sperm head and tail that lead to the release of the acrosomal
content (acrosome reaction, AR) and to the acquisition of a
distinct type of motility known as hyperactivation. Both events
are essential for sperm penetration through the egg coatings
(Yanagimachi, 1994).
The molecular basis of capacitation is not well understood.
Results from several laboratories have shown that capacitation
is associated with a phosphorylation cascade. In particular,
several proteins undergo a cyclic adenosine monophosphate
(cAMP)-dependent increase in tyrosine phosphorylation
(Visconti et al., 1995a; Visconti et al., 1995b). Many of these
proteins are Triton X-100 insoluble, localize to the principal
piece of the flagellum, and have been proposed to be involved
in the regulation of sperm motility (Carrera et al., 1996). In
this respect sperm tail proteins, A kinase-anchoring
proteins (AKAP) 3 and 4, undergo capacitation-dependent
phosphorylation in both tyrosine and serine residues (Carrera
et al., 1996; Ficarro et al., 2003; Mandal et al., 1999),
suggesting that both tyrosine and serine/threonine kinases
participate in sperm motility regulation.
In addition to the role of phosphorylation signalling in sperm
motility, studies with a variety of species have shown that Ca2+
ions play a key role in the development and maintenance of
sperm progressive motion and hyperactivation (Lindemann et
al., 1991; Serres et al., 1991; Marin-Briggiler et al., 1999;
Marin-Briggiler et al., 2003; Marquez and Suarez, 2004).
Using demembranated sperm models, some of these
investigations have revealed that Ca2+ levels modulate the
waveform of the sperm tail (Ho et al., 2002; Lindemann
and Goltz, 1988). However, the underlying Ca2+-regulated
pathways involved in the initiation and maintenance of sperm
motility have not yet been fully characterized. Ca2+ can directly
bind to membrane phospholipids and to several enzymes, with
the subsequent modification of membrane properties and
enzymatic activity. This cation may also act through binding
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The mechanisms involved in the regulation of mammalian
sperm motility are not well understood. Calcium ions
(Ca2+) have been suggested to play a key role in the
maintenance of motility; nevertheless, how Ca2+ modulates
this process has not yet been completely characterized.
Ca2+ can bind to calmodulin and this complex regulates the
activity of multiple enzymes, including Ca2+/calmodulin-
dependent protein kinases (CaM kinases). Results from this
study confirmed that the presence of Ca2+ in the incubation
medium is essential for maintaining human sperm motility.
The involvement of CaM kinases in Ca2+ regulation of
human sperm motility was evaluated using specific
inhibitors (KN62 and KN93) or their inactive analogues
(KN04 and KN92 respectively). Sperm incubation in the
presence of KN62 or KN93 led to a progressive decrease in
the percentage of motile cells; in particular, incubation with
KN62 also reduced sperm motility parameters. These
inhibitors did not alter sperm viability, protein tyrosine
phosphorylation or the follicular fluid-induced acrosome
reaction; however, KN62 decreased the total amount of
ATP in human sperm. Immunological studies showed that
Ca2+/calmodulin-dependent protein kinase IV (CaMKIV)
is present and localizes to the human sperm flagellum.
Moreover, CaMKIV activity increases during capacitation
and is inhibited in the presence of KN62. This report is the
first to demonstrate the presence of CaMKIV in
mammalian sperm and suggests the involvement of this
kinase in the regulation of human sperm motility.
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to calmodulin (CaM); in this regard, a recent study (Si and
Olds-Clarke, 2000) demonstrated that CaM antagonists
inhibited different aspects of sperm function, including the
onset of sperm hyperactivation. Ca2+ binding to CaM changes
its conformation and the Ca2+/CaM complex regulates the
activity of multiple enzymes, including adenylyl cyclases
(Gross et al., 1987; Mons et al., 1999), phosphatases (Rusnak
and Mertz, 2000; Tash et al., 1988), phosphodiesterases
(Wasco and Orr, 1984) and protein kinases (Hook and Means,
2001). Most of these enzymes are present in mammalian sperm
and appear to be involved in the regulation of flagellar bending
(Turner, 2003). Recently, Zeng and Tulsiani (Zeng and
Tulsiani, 2003) demonstrated that CaM has a role in sperm
capacitation. These authors used different CaM antagonists and
showed that although some affected motility without altering
sperm viability, all of them inhibited the agonist-induced
acrosome reaction. These results strongly suggest that CaM
antagonists can prevent capacitation by interfering with
multiple regulatory pathways. Consistent with these results are
the aforementioned multiple targets for CaM action.
Kinases regulated by Ca2+/CaM belong to a subfamily
known as CaM kinases (CaMK) comprised of CaMKI, II and
IV. CaM kinases are serine/threonine kinases that
phosphorylate transcription factors and thus, play a major role
in Ca2+-regulated gene expression in somatic cells. CaM
kinases have limited tissue distribution; presence of these
enzymes has been reported in brain, thymus, bone marrow,
ovary and testis (Means et al., 1991). Several reports indicate
that CaMKII is expressed in oocytes and is activated during
fertilization, mediating meiosis resumption and cortical
granule exocytosis (Johnson et al., 1998; Lorca et al., 1993).
Regarding the testis, CaMKIV has been localized to mouse
spermatogonia and spermatids. In elongating spermatids
(transcriptionally inactive cells), CaMKIV is associated with
the nuclear matrix and might be involved in chromatin
remodelling during nuclear condensation (Wu and Means,
2000). Two recent studies focused on CaMKIV-deficient mice
fertility: one reported that these animals are infertile owing to
impaired spermiogenesis and replacement of basic nuclear
proteins by protamines (Wu et al., 2000a), the other found that
they exhibited normal spermatogenesis and fertility (Blaeser et
al., 2001). The presence and role of these enzymes in sperm
have not yet been described. 
In this work, we have attempted to examine the potential
mechanisms involved in the Ca2+ regulation of human sperm
motility. Evidence is presented showing that incubation of
human sperm with inhibitors of the CaM kinase family (KN62
and KN93), but not with their inactive analogues (KN04 and
KN92, respectively), results in a significant decrease of sperm
motility and ATP content. In addition, we show that CaMKIV
is present in mammalian sperm and localizes to the flagellum.
Materials and Methods
Culture media
Modified Tyrode’s medium, HSM (Suarez et al., 1986), was used
throughout the study. It consisted of 117.5 mM NaCl, 0.3 mM
NaH2PO4, 8.6 mM KCl, 0.49 mM MgCl2, 2 mM glucose, 19 mM
sodium lactate, 25 mM NaHCO3, 0.25 mM sodium pyruvate, 50
µg/ml penicillin and 75 µg/ml streptomycin. The medium not
supplemented with CaCl2 was called ‘–Ca2+’. When this medium was
supplemented with 2.6% bovine serum albumin (BSA; Sigma
Chemical Co., St Louis, MO), it contained 0.1 mM Ca2+, as
determined by atomic absorption. These measurements were carried
out by Pharma Control laboratory, Buenos Aires, Argentina, using a
Shimadzu AA-660 spectrophotometer as described (Association of
Official Analytical Chemists, 2000). To prepare media with
increasing Ca2+ concentrations, different amounts of a stock solution
of 22.5 mM CaCl2 were added to –Ca2+ +2.6% BSA, giving the
following final concentrations of Ca2+: 0.22, 0.58, 1.5 and 2.5 mM.
Medium containing maximum amounts of CaCl2 (2.5 mM) was
called ‘+Ca2+’. All these media had similar osmolarity (308-314
mOsm).
Semen samples and sperm processing
Semen samples were obtained from normozoospermic volunteers
according to WHO standards (WHO, 1999). In each experiment,
ejaculates from different men were used. After complete liquefaction,
samples were subjected to sperm selection using glass wool columns
(Microfibre Manville, Denver, CO) (Calvo et al., 1989) and highly
motile cells were resuspended in –Ca2+ medium supplemented with
2.6% BSA. In some cases (western blot and CaMKIV activity
experiments), sperm separation was carried out using Percoll™
gradients, as described (Ficarro et al., 2003). Sperm concentration
was adjusted to 5106 cells/ml and up to 2 ml aliquots were
incubated under different conditions at 37°C, 5% CO2 in air for
different periods of time as stated. When indicated, CaM kinase
inhibitors KN62 and KN93 (Calbiochem, San Diego, CA) or their
inactive analogues KN04 (Seikagaku, Tokyo, Japan) and KN92
(Calbiochem), were added immediately after sperm filtration. These
compounds were originally prepared as 20 mM stock solutions
in DMSO. In each experiment, an aliquot containing DMSO
concentrations equivalent to the maximum concentration of
inhibitors used (0.3 to 0.5% depending on the experiment), was
included. After a 30-minute incubation, all aliquots were
supplemented with 2.5 mM CaCl2, except one that served as control
(–Ca2+). Post incubation motility was determined by observation
under light microscopy (400 magnification; Alphaphot-2 YS2,
Nikon, Tokyo, Japan) or by computer-assisted sperm analysis (see
below). Sperm viability was assessed using 0.5% Eosin Y in aqueous
0.9% NaCl solution, as indicated (WHO, 1999). In all cases, at least
200 cells were scored.
Computer-assisted sperm analysis (CASA)
Aliquots of 50,000 sperm incubated for 18 hours under different
experimental conditions were placed in a MicroCell™ chamber
(Conception Technologies, San Diego, CA) and analysed using an
IVOS V10.8s CASA instrument (Hamilton-Thorne Research,
Beverly, MA). The settings used during the analysis were: number of
frames acquired=30, frame rate=60 Hz, minimum contrast=80,
minimum cell size=3 pixels, minimum static contrast=30. The
kinematic values for at least 200 motile sperm were analysed in each
sample.
To determine the percentage of hyperactivated sperm, analysis was
performed after a 4-hour incubation under different conditions. Cells
with curvilinear velocity (VCL)100 µm/second, lateral head
displacement (ALH)5 µm and linearity (LIN)60% were
considered hyperactivated (Mortimer and Mortimer, 1990).
Electrophoresis and western blots
Presence of CaM kinases was evaluated in protein extracts from non-
capacitated human sperm. Cells were washed twice with PBS,
resuspended in sample buffer in the absence of 2-β-mercaptoethanol
(Laemmli, 1970), boiled and centrifuged at 6000 g for 5 minutes. The
supernatants were removed and heated at 100°C in the presence of
Journal of Cell Science 118 (9)
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2-β-mercaptoethanol (5% final concentration) for 5 minutes.
Following centrifugation, the supernatants were stored at –20°C until
use. Solubilized proteins, corresponding to 2106 sperm (3 µg
protein measured using the ABC kit from Pierce) per lane, were
separated under reducing conditions by 12% SDS-PAGE (Laemmli,
1970). For two-dimensional (2-D) gel analysis, sperm were
solubilized in a lysis buffer (Celis) consisting of 2% (v/v) NP-40, 9.8
M urea, 100 mM dithiothreitol (DTT), 2% (v/v) ampholines (pH 3.5-
10), and the protease inhibitors 2 mM PMSF, 5 mM iodoacetamide,
5 mM EDTA, 3 mg/ml L-1chlor-3-(4-tosylamido)-7-amino-2-
heptanon-hydrochloride (TLCK), 1.46 µM pepstatin A and 2.1 µM
leupeptin. 5108 cells/ml were solubilized by constant shaking
at 4°C for 60 minutes. Insoluble material was removed by
centrifugation. 65 µl sperm extract (approximately 0.15 mg of
protein) were subjected to 2-D gel electrophoresis as described
(Ficarro et al., 2003). Electrophoretic transfer was carried out as
detailed (Kalab et al., 1994) and membranes were blocked with PBS
containing 10% fish gelatin and 0.1% Tween 20 (Sigma). Monoclonal
anti-CaMKIV or anti-CaMKII (Transduction Laboratories,
Lexington, KY; 1:2000) were used as primary antibodies. Blots were
washed four times for 5 minutes, and incubated with anti-mouse
peroxidase-conjugated IgG (Jackson ImmunoResearch Laboratories,
West Grove, PA) (1:5000).
Tyrosine-phosphorylated proteins were detected in cells incubated
for 18 hours under different experimental conditions. Sperm were
processed as previously detailed (Marin-Briggiler et al., 1999).
Extracts (corresponding to 2106 sperm or 3 µg protein per lane)
were subjected to 7% SDS-PAGE, and protein transferred onto
nitrocellulose membranes. Loading of equal amounts of protein in
each lane was checked by Ponceau staining. Phosphotyrosine residues
were detected using a monoclonal antibody (clone 4G10, Upstate
Biotechnology, NY; 1:10,000). Blots were washed four times for 5
minutes, and secondary antibody (1:5000) was added for 1 hour. After
incubation with the antibodies, membranes were extensively washed
and reactive bands were detected by enhanced chemiluminescence
using the ECL kit (Amersham Life Science, Oakville, ON) according
to the manufacturer’s instructions. All incubations were performed at
room temperature.
Acrosome reaction (AR) assessment
To determine whether CaM kinases are involved in human sperm AR,
CaM kinase inhibitors (60 µM) were added immediately after sperm
recovery. 30 minutes later, sperm suspensions were supplemented
with 2.5 mM Ca2+ and incubated for an additional 18 hours. Aliquots
incubated in medium supplemented or not with CaCl2 (+Ca2+ and
–Ca2+, respectively) served as controls. Induction of the AR was
performed at the end of the incubation period by sperm exposure to
10% human follicular fluid (hFF) or buffer for 45 minutes at 37°C,
5% CO2 in air (Marin-Briggiler et al., 1999). After this procedure,
sperm were fixed and the AR evaluated by staining with 50 µg/ml
fluorescein isothiocyanate (FITC)-labelled Pisum sativum agglutinin
(Sigma) as previously described (Marin-Briggiler et al., 1999).
Stained cells (at least 200 cells per treatment) were scored in a
microscope equipped with epifluorescence (Nikon Labophot, Tokyo,
Japan). Presence of a bright staining over the acrosome was
indicative of intact sperm; cells with partial or patchy staining, with
fluorescence restricted to the equatorial segment or lack of staining
were considered acrosome reacted. Under the conditions used in
these experiments the predominant patterns were the bright staining
over the acrosome or the equatorial segment fluorescence. The patchy
staining was restricted to less than 3% of the cells in all the conditions
analysed.
Determination of ATP levels
ATP concentration was measured in sperm (10106/ml) incubated for
18 hours under different experimental conditions. Capacitation
medium (0.4 ml) was removed by centrifugation, and the sperm pellet
was washed twice with PBS. Cells were resuspended in 0.1 ml PBS,
placed in glass tubes and 0.4 ml of Tris-acetate buffer (Labsystems,
Helsinki, Finland) was added. Samples were heated at 100°C for 15
minutes to release intracellular ATP and stored at –20°C until use.
ATP was measured using a kit from Labsystems according to the
manufacturer’s instruction. Briefly, on the day of the measurement,
0.3 ml Tris-acetate buffer and 0.1 ml ATP monitoring reagent
(Labsystems) were mixed in a cuvette and background light emission
(B value) was recorded in a luminometer (1250, LKB Wallac, Turku,
Finland). 0.1 ml of the sample was added, and luminescence was
measured (S value). After addition of 0.05 nmoles of standard ATP
solution (Labsystems), the I value was determined. S and I values were
corrected for background luminescence (Sc and Ic, respectively) and
results were calculated as: nmoles ATP per 106 cells=[Sc/(Ic–Sc)] 
0.05 nmoles.
Immunofluorescence microscopy
Non-capacitated sperm were air-dried onto glass slides, washed three
times with PBS, permeabilized with methanol, washed again with
PBS and blocked with 10% normal goat serum (NGS) in PBS.
Incubations were then carried out with anti-CaMKIV and anti-
CaMKII antibodies (Transduction Laboratories, 1:250) or normal
mouse serum (1:250) diluted in PBS with 1% NGS (PBS-NGS). After
washing, slides were incubated with FITC-conjugated F(Ab)2
fragments of donkey anti-mouse IgG (Jackson ImmunoResearch
Laboratories) (1:200) in PBS-NGS, washed with PBS and mounted
with Slow-Fade Light (Molecular Probes, Eugene, OR). Sperm were
observed by differential interference contrast and epifluorescence
microscopy using a Zeiss axiophot microscope (Carl Zeiss,
Thornwood, NY).
CaM kinase IV activity
CaMKIV activity was measured in motile sperm treated immediately
after Percoll™ selection and resuspension in the incubation medium
or in sperm incubated for 18 hours in capacitating conditions in the
absence or presence of 60 µM KN62. Sperm subjected to these
different experimental conditions were washed twice with PBS, cell
concentration was adjusted to 107 cells/ml, and aliquots were stored
at –20°C until use. After thawing, 10 µl sperm suspension were
mixed with an equal amount of 2 reaction buffer, consisting of 25
mM HEPES, 40 µM ATP, 1 µCi/assay [γ-32P]ATP, 10 mM MgCl2,
10 µM aprotinin and leupeptin, 100 µM Na3VO4, 5 mM p-NO2-
phenol phosphate, 40 mM glycerophosphate, 1% Triton X-100, 1
mg/ml BSA and 100 µM peptide gamma (Biomol, PA), as specific
substrate. After a 15-minute incubation at 37°C, the reaction was
stopped with the addition of 20 µl of 20% trichloroacetic acid as
described (Visconti et al., 1997). Samples were placed on ice for 20
minutes, centrifuged, and 30 µl supernatant were spotted onto
phosphocellulose paper (22 cm Whatman p 81). After five washes
with 5 mM phosphoric acid, the phosphocellulose papers were dried
and placed in vials. 2.5 ml scintillation fluid was added to each vial
and counted in a scintillation counter. Assays were run in triplicate
and results were expressed as fmoles of 32P incorporated/106
sperm/minute.
Statistical analysis
Data were expressed as mean±s.e.m. To assume normal distribution,
percentages were converted to ratios, and subjected to the arcsine
square root transformation. Data were compared by one- or two-way
ANOVA and Student-Newman-Keuls multiple comparison test.
Statistical analyses were performed using the GraphPad InStat
program (GraphPad Software, San Diego, CA).
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Results
Calcium ions are required for the maintenance of human
sperm motility in vitro
To determine the requirement of extracellular Ca2+ for the
maintenance of human sperm motility in vitro, cells were
incubated for up to 18 hours in medium not supplemented with
CaCl2 (–Ca2+: containing 0.1 mM contaminating Ca2+ as
determined by atomic absorption) or containing increasing
concentrations of this cation (0.22, 0.58, 1.5 and 2.5 mM), and
the percentage of progressively motile and viable cells were
determined. When sperm were incubated in –Ca2+ medium
there was a significant decline in the percentage of motile cells
compared to other conditions (Fig. 1A); such a decrease was
not due to cell death (Fig. 1B). In contrast, maximum
percentages of motility and viability were obtained in cells
incubated in the presence of 0.22 mM or higher Ca2+
concentrations (Fig. 1).
CaM kinase inhibitors decrease human sperm motility
The aforementioned results showing that Ca2+ are required for
the maintenance of human sperm motility, added to the
findings that some CaM antagonists inhibit mouse sperm
motion (Si and Olds-Clarke, 2000; Zeng and Tulsiani, 2003),
suggest that the effect of Ca2+ may be mediated through a
Ca2+/CaM pathway. This evidence suggests that CaM kinases
may also participate in the modulation of mammalian sperm
motility. To analyse this possibility, motile human sperm were
suspended in medium not supplemented with Ca2+ in the
presence or absence of CaM kinase inhibitors (KN62 and
KN93), or their inactive analogues (KN04 and KN92,
respectively). These compounds were added to give the
following final concentrations: 1, 3, 10, 30, 60, 100 µM. CaM
kinase inhibitors are competitive inhibitors of the activation of
CaM kinases by Ca2+/CaM; therefore, to maximize their
activity, they were added before supplementation with Ca2+.
After a 30-minute incubation, aliquots were supplemented
with CaCl2 to a final concentration of 2.5 mM and sperm were
incubated for 18 hours in capacitating conditions. Aliquots
incubated in –Ca2+ medium, in the absence of the inhibitors,
or in the presence of the maximum concentration of DMSO
served as controls. Overnight incubation with KN62 led to a
concentration-dependent and significant reduction in the
percentage of motile cells (Fig. 2A). These percentages were
similar to those obtained in medium not supplemented with
Ca2+. Incubation with increasing concentrations of KN93 also
produced a decrease in sperm motility, although the decline
was not as pronounced as that observed with KN62. The effect
of CaM kinase inhibitors upon sperm motion was specific, as
no decrease in the percentage of motile sperm was observed
in the presence of similar concentrations of the inactive
analogues of the CaM kinase inhibitors or in the presence of
DMSO (Fig. 2A). The percentage of viable cells was similar
in all conditions (Fig. 2B).
To further investigate the involvement of CaM kinases in the
development and maintenance of human sperm motility, cells
were incubated in the presence of KN62 or KN04 (60 µM) as
previously described, and the percentage of motile and live
cells at different time points was determined. The results
revealed that KN62 causes a significant and progressive decline
in the percentage of motile sperm (Fig. 3A). The values
obtained in the presence of 60 µM KN62 were similar to those
observed in cells incubated for the same period of time in the
–Ca2+ medium. In all the conditions tested, sperm remained
viable throughout the incubation period (Fig. 3B).
The effect of KN62 upon sperm motility was also studied
using computer-assisted sperm analysis (CASA) of motion
parameters. Experiments were conducted after an 18-hour
incubation in –Ca2+ medium, and in the presence of Ca2+ with
or without the addition of 60 µM KN62 or its inactive analogue
KN04 (Table 1). When incubations were carried out in the
presence of KN62 or in –Ca2+ medium, there was a reduction
in the percentage of progressive cells, in the average path
velocity (VAP), in the straight-line velocity (VSL) and in the
percentage of cells displaying rapid motion (Grade 4); the
decrease in these parameters observed in the presence of KN62
was similar to that observed in –Ca2+. Confirming the results
shown (Figs 1-3), human sperm incubated in the presence of
KN62 or in medium not supplemented with Ca2+ showed a
significant increase in the percentage of static sperm (Grade 1).
In cells incubated in both conditions, other sperm motility
parameters such as the curvilinear velocity (VCL), the
amplitude of lateral head displacement (ALH), the beat/cross
frequency (BCF), the percentage of straightness (STR) and the
percentage of linearity (LIN) were slightly decreased, but they
did not show significant differences when compared to
controls.
Several reports indicate that the cyclic adenosine
Journal of Cell Science 118 (9)
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Fig. 1. Ca2+ requirement for the
maintenance of human sperm motility and
viability. Motile sperm selected using glass
wool columns were incubated for up to 18
hours at 37°C in medium not
supplemented with CaCl2 (–Ca2+, ), or
containing different concentrations of
CaCl2: 0.22 mM (), 0.58 mM (), 1.5
mM () or 2.5 mM (). The percentages
of progressively motile (A) and live (B)
cells after 1, 2, 4, 6 and 18-hour incubation
were determined as described in Materials
and Methods. The results are expressed as
mean±s.e.m., n=7. *P<0.05 when
compared to sperm motility under all other
conditions.
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monophosphate/protein kinase A (cAMP/PKA) pathway is
involved in the regulation of flagellar bending (Eddy and
O’Brien, 1994; Luconi and Baldi, 2003). To determine the
relationship between this pathway and that involving CaM
kinases, 1 mM dibutyryl cAMP (a cAMP agonist) and 200
µM isobutyl-methylxanthine (a cAMP phosphodiesterase
inhibitor) were simultaneously added with KN62 (60 µM), and
the effect upon sperm motion was assessed. The addition of
these compounds could not restore motility in cells incubated
with KN62 for 18 hours (data not shown), suggesting that CaM
kinases participate in motility regulation downstream to or
independently from a cAMP/PKA pathway.
Because previous works in sperm from different species
(Marin-Briggiler et al., 2003; Marquez and Suarez, 2004) have
shown that Ca2+ is required for the development of
hyperactivated motility, the possibility that CaM kinases are
involved in the regulation of hyperactivation was also analysed.
Hyperactivation parameters were investigated as described in
human sperm incubated for 4 hours under capacitating
conditions, in media supplemented or not with Ca2+ and in the
presence or in the absence of 60 µM KN62 or its inactive
analogue KN04. In Ca2+-containing medium (2.5 mM), the
percentage of hyperactivated cells was 19±3%. As reported
(Marin-Briggiler et al., 2003), the development of this type of
motility was significantly inhibited in –Ca2+ medium (3±1%).
Although incubation with KN62 reduced the percentage of
cells displaying hyperactivation to 10±2%, a similar reduction
was observed in the presence of KN04 (8±1%), suggesting a
non-specific effect of these compounds on hyperactivation.
CaM kinase inhibitors do not inhibit the Ca2+-induced
decrease in tyrosine phosphorylation or the hFF-induced
acrosome reaction
The development of mammalian sperm motility and the
occurrence of capacitation has been related to phosphorylation
of several sperm proteins on tyrosine residues (Osheroff et al.,
1999; Visconti et al., 2002). In human sperm, as well as in
mouse sperm under certain conditions, the presence of Ca2+
in the incubation medium decreases protein tyrosine
phosphorylation levels (Carrera et al., 1996; Luconi et al.,
1996; Marin-Briggiler et al., 2003; Baker et al., 2004). CaM
Fig. 2. Concentration curve of CaM
kinase inhibitors effect upon human
sperm motility and viability.
Immediately after selection using glass
wool columns, motile sperm were
resuspended in medium not
supplemented with CaCl2, and in the
presence or absence of the CaM kinase
inhibitors KN62 () or KN93 (); or
their inactive analogues KN04 () and
KN92 () at the following final
concentrations: 1, 3, 10, 30, 60, 100
µM. After 30 minutes, aliquots were
supplemented with CaCl2 (final
concentration: 2.5 mM) and cells were
incubated for 18 hours in capacitating
conditions. Aliquots incubated in
medium not supplemented with CaCl2
(– Ca2+, ), in the absence of the inhibitors (+ Ca2+, ), or in the presence of 0.5% DMSO (DMSO, ) served as controls. The percentages of
progressively motile (A) and live (B) cells were determined. The results are expressed as mean±s.e.m., n=6. *P<0.01 when compared to sperm
motility under all other conditions.
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Fig. 3. Time curve of the effect of CaM
kinase inhibitor (KN62) and its inactive
analogue (KN04) upon human sperm
motility and viability. Immediately
after selection with glass wool
columns, motile sperm were
resuspended in medium not
supplemented with CaCl2, and 60 µM
KN62 () or KN04 () were added.
After 30 minutes, aliquots were
supplemented with CaCl2 (final
concentration: 2.5 mM) and cells were
incubated for up to 18 hours in
capacitating conditions. Aliquots
incubated in medium not supplemented
with CaCl2 (–Ca2+, ) and in the
absence of the inhibitors (+Ca2+, 	)
served as controls. The percentages of
progressively motile (A) and live (B) cells after 1, 2, 4, 6 and 18-hour incubations were determined. The results are expressed as mean±s.e.m.,
n=7. *P<0.01 when compared with sperm motility under control conditions.
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antagonists have been shown to inhibit this Ca2+-induced
decrease in protein tyrosine phosphorylation (Carrera et al.,
1996). In the present report we explored whether Ca2+ effect
was linked to the activation of CaM kinases. Motile sperm
were treated as previously indicated, and protein tyrosine
phosphorylation patterns were analysed by western blotting
using an anti phosphotyrosine antibody. As expected, sperm
incubated in –Ca2+ medium showed higher levels of protein
tyrosine phosphorylation than those incubated in the presence
of this divalent cation (+Ca2+). Similar low levels of protein
tyrosine phosphorylation were obtained either in the presence
of KN62, KN04 (60 µM), DMSO (Fig. 4A,B), KN93 or KN92
(data not shown). These results suggest that in human sperm,
CaM kinases do not participate in the Ca2+-associated decrease
in protein tyrosine phosphorylation.
Considering that Ca2+ and CaM are involved in the
regulation of the acrosomal loss in response to physiological
and pharmacological stimulus (Bendahmane et al., 2001;
Lopez-Gonzalez et al., 2001; Marin-Briggiler et al., 1999; Si
and Olds-Clarke, 2000), participation of CaM kinases in this
event was investigated. Motile sperm were suspended in
medium not supplemented with Ca2+ in the absence or in the
presence of KN62 or KN93 (60 µM). After 30 minutes, all the
aliquots except the –Ca2+ ones, were supplemented with CaCl2
to a final concentration of 2.5 mM. The sperm were incubated
in these conditions for 18 hours and then each sample was
exposed to 10% human follicular fluid (hFF) or buffer for 1
hour. Sperm incubated in –Ca2+ medium were not able to
undergo the AR in response to hFF (Fig. 5). In contrast,
incubation with CaM kinase inhibitors from the beginning of
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Table 1. Kinematic characteristics of human sperm
incubated with a CaM kinase inhibitor or its inactive
analogue
–Ca2+ KN62 KN04 +Ca2+
Total motility (%) 15±6** 26±9** 66±5 74±2
Progressive (%) 5±4* 13±7* 42±10 56±6
VAP 33±3* 37±5* 47±7 54±4
VSL 24±4* 30±6 41±8 48±5
VCL 66±8 64±6 75±6 84±4
ALH 2±1 4±1 4±1 4±1
BCF 23±6 22±1 22±1 26±4
STR 70±5 78±3 84±5 87±3
LIN 38±3 45±4 52±7 56±5
Grade 4 (%) 13±7* 19±8* 54±7 68±2
Grade 3 (%) 2±1* 7±2 12±2 7±1
Grade 2 (%) 7±3 6±4 12±1 10±3
Grade 1 (%) 78±10** 68±13** 22±6 16±4
Immediately after selection using glass wool columns, motile sperm were
resuspended in medium not supplemented with CaCl2, and 60 µM KN62 or
KN04 were added. After 30 minutes, aliquots were supplemented with CaCl2
(final concentration: 2.5 mM) and cells were incubated for up to 18 hours in
capacitating conditions. Aliquots incubated in medium not supplemented with
CaCl2 (–Ca2+) and in the absence of the inhibitor or the inactive analogue
(+Ca2+) served as controls. Parameters measured: average path velocity (VAP,
µm/second), straight-line velocity (VSL, µm/second), curvilinear velocity
(VCL, µm/second), amplitude of lateral head displacement (ALH, µm),
beat/cross frequency (BCF, Hz), straightness (STR,%), linearity (LIN,%).
According to their motility, individual sperm were classified as Grade 4 (rapid
motion, VAP >25 µm/second), Grade 3 (slow motion, VAP 25-5 µm/second),
Grade 2 (in situ motility, VAP <5 µm/second), Grade 1 (static cells). The
results are expressed as mean±s.e.m., n=3.
*P<0.05, **P<0.01 when compared to values in KN04 and +Ca2+ treated
cells. 
Fig. 4. Effect of KN62 on the Ca2+-associated decrease in protein
tyrosine phosphorylation. Immediately after selection using
Percoll™ gradients, motile sperm were resuspended in medium not
supplemented with CaCl2, and 60 µM KN62 or KN04 were added.
After 30 minutes, aliquots were supplemented with CaCl2 (final
concentration: 2.5 mM) and cells were incubated for 18 hours under
capacitating conditions. Aliquots incubated in medium not
supplemented with CaCl2 (–Ca2+) and in the absence of the inhibitors
(+Ca2+) or in the presence of 0.3% DMSO (DMSO) served as
controls. Sperm protein extracts (2106 cells per lane) were
analysed by PAGE, immunoblotted and probed using a monoclonal
antibody against phosphotyrosine (clone 4G10, Upstate
Biotechnology). Molecular weight standards (10–3) are indicated
on the left. Panel A, 2-minute exposure; Panel B, 10-minute
exposure. A typical experiment is shown. This experiment was
performed three times obtaining similar results.
mreps
 detcaer
 e
m
os
orca
 
%
0
10
20
30
40
50
*
*
*
Ca2+
- - - - +     +         - -
KN93
KN62
hFF
- - - - - - +      +   
- - +     +        +     +        +   +   
- +         - +        - +         - +   
 
 
 
Fig. 5. Effect of CaM kinase inhibitors upon hFF-induced acrosome
reaction. After selection using glass wool columns, motile sperm
were resuspended in medium not supplemented with CaCl2 in the
presence or absence of 60 µM KN62 or KN93. 30 minutes later,
aliquots were supplemented with CaCl2 (final concentration: 2.5
mM). Aliquots incubated in media not supplemented with Ca2+
(–Ca2+) and in the absence of the inhibitors (+Ca2+) served as
controls. After an 18-hour incubation period, the sperm were
exposed to 10% human follicular fluid (hFF) or buffer for 45 minutes
and the acrosomal status determined using FITC-Pisum sativum
agglutinin. The results are expressed as mean±s.e.m., n=4. *P<0.001
compared to acrosomal status of cells with no hFF added under all
conditions and cells with hFF but no Ca2+.
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the 18-hour incubation period did not prevent the occurrence
of hFF-induced acrosome reaction.
Inhibition of CaM kinases reduces sperm ATP content
One parameter that could affect the maintenance of sperm
motility is the availability of ATP. When human sperm were
incubated for 18 hours in medium not supplemented with Ca2+,
the ATP concentration was significantly reduced compared to
cells incubated in the presence of Ca2+ (Table 2). Similarly,
KN62 but not KN04, reduced the sperm ATP levels when
present in the incubation medium (Table 2). These results
suggest that CaM kinase antagonists inhibit sperm motility
by reducing ATP availability by either a decrease in energy
production or by an increased consumption of ATP in other
pathways.
Presence, localization and activity of CaM kinase IV in
human sperm
The inhibitory effect observed with KN62 and KN93 suggests
that CaM kinases are involved in the regulation of human
sperm motility. Expression of CaMKIV has been reported in
rodent male germ cells (Wu and Means, 2000), though its
presence, localization and role in sperm are still unknown.
Anti-CaMKIV antibodies were used to determine whether this
enzyme is present in human sperm by western blotting. In one-
dimensional gels, a protein of 61 kDa was detected (Fig. 6A);
two-dimensional western blots detected a series of spots of the
expected molecular mass and isoelectric point (Fig. 6B). These
data indicate that CaMKIV is present in human sperm.
Contrasting with these findings, no protein bands were detected
when anti CaMKII was used (data not shown).
To analyse the subcellular localization of CaMKIV in human
sperm, indirect immunofluorescence using the same antibody
was performed. Sperm incubated with anti-CaMKIV showed
a positive signal throughout the flagellum, with a brighter
fluorescence in the middle piece (Fig. 6C). Staining was
specific, as no signal was evident when normal mouse serum
was used (data not shown).
To further investigate the presence of CaMKIV in human
sperm, its enzymatic activity was determined using peptide
gamma as a substrate. This peptide contains a specific
consensus sequence for phosphorylation by CaMKIV
(Gringhuis et al., 1997). Sperm incubated for 18 hours in
capacitating conditions (Fig. 7, T18) showed a significant
increase in the incorporation of 32P to peptide gamma when
compared with cells that were resuspended in
complete medium and immediately processed for
the kinase measurement (Fig. 7, T0). This increase
was abolished in sperm incubated in the presence
of KN62 during the capacitation period [Fig. 7, T18
(KN62)].
Discussion
The initiation and maintenance of sperm motility is
a complex phenomenon that involves the activation
of several signal transduction pathways. Evidence
from the present study has confirmed that Ca2+ ions
Table 2. ATP content of sperm incubated with the CaM
kinase inhibitor KN62 or its inactive analogue
Condition nmoles of ATP per 106 sperm % relative to +Ca2+ condition
–Ca2+ 0.09±0.02* 50
KN62 0.12±0.02* 67
KN04 0.18±0.02 100
DMSO 0.17±0.02 94
+Ca2+ 0.18±0.02 100
Immediately after selection using glass wool columns, motile sperm were
resuspended in medium not supplemented with CaCl2 in the presence or
absence of 60 µM KN62 or KN04. After 30 minutes, aliquots were
supplemented with CaCl2 (final concentration: 2.5 mM) and cells were
incubated for 18 hours in capacitating conditions. Aliquots incubated in
medium not supplemented with CaCl2 (–Ca2+), in the absence of the inhibitor
or the inactive analogue (+Ca2+) or with 0.3% DMSO served as controls. ATP
content was determined in each aliquot. The results are expressed as
mean±s.e.m., n=6.
*P<0.01 when compared to levels in KN04, DMSO and +Ca2+ treated
cells. 
Fig. 6. Presence and localization of CaM kinase IV in
human sperm. Human sperm extracts were subjected to
one-dimensional (A) and two-dimensional (B) gel
electrophoresis, followed by western immunoblotting
using a monoclonal anti-CaMKIV antibody
(Transduction Laboratories). Both, pI and relative
molecular mass (10–3) are indicated. This experiment
was performed three times obtaining similar results. A
typical experiment is shown. (C) Localization of
CaMKIV in human sperm by indirect
immunofluorescence. Non-capacitated sperm were fixed
and processed for indirect immunofluorescence using
monoclonal anti-CaMKIV antibody (IF). The
corresponding bright field photomicrograph is also
shown. Bar, 10 µm.
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are required to support human sperm motility, and indicate that
members of the CaM kinase family, particularly CaMKIV, are
important signalling components in this process. The need for
Ca2+ in the regulation of sperm function has been widely
reported (reviewed by Fraser, 1995). Our results show that
when human sperm are incubated in medium not supplemented
with CaCl2, progressive motility is significantly reduced, and
that 0.22 mM of this cation is sufficient to maintain flagellar
motion. Similar Ca2+ concentrations are required for the
occurrence of some capacitation-related events such as the
development of hyperactivated motility (Marin-Briggiler et al.,
2003).
Contrasting with the large amount of evidence showing the
need of Ca2+ for the modulation of mammalian sperm motility,
the underlying molecular mechanisms and target proteins have
not yet been characterized. CaM has been identified as a
component of ciliary and flagellar axonemes, and it has been
proposed as the Ca2+ sensor that mediates motility in cells from
a wide variety of species, including sperm from mammals and
echinoderms (Brokaw, 1991; Lindemann et al., 1991; Plattner
and Klauke, 2001; Si and Olds-Clarke, 2000). In humans,
CaM concentration has been shown to be decreased in
asthenozoospermic patients (Reyes et al., 1987). Additionally,
some CaM inhibitors negatively affected sperm motility
parameters and led to a reduction in the percentage of motile
and hyperactivated cells (Ahmad et al., 1995; Aitken et al.,
1988). Recently, six different CaM antagonists were shown to
inhibit the agonist-induced acrosome reaction in mouse sperm
(Zeng and Tulsiani, 2003); three of these compounds (48/80,
W13 and the CaM-binding domain) had no effect on sperm
motility or tyrosine phosphorylation. In contrast, three others
(W7, ophiobolin A and calmidazolium) inhibited tyrosine
phosphorylation and sperm motility without altering viability.
These results suggest that CaM is involved in the regulation of
different sperm parameters. Because this protein can interact
with several enzymes, it is predicted that CaM antagonists
could prevent the activation of multiple pathways.
Among the multiple targets of CaM are the family of CaM
kinases. A recent study in Chlamydomonas has shown that
Ca2+ controls dynein-driven microtubule sliding through the
activation of axonemal CaM and CaM kinase, as dynein
activity was abolished when isolated axonemes were exposed
to CaM or CaMKII inhibitors (Smith, 2002). In the present
report, using membrane-permeable inhibitors and their inactive
analogues as controls, we were able to demonstrate the
involvement of CaM kinases in the regulation of human sperm
motility. In the presence of the active inhibitor KN62, a
significant and specific decline in progressive motility and a
reduction in sperm motion parameters were observed. When
sperm were incubated with KN93 CaM kinase inhibitor,
motility was also negatively affected, although the effect was
not as pronounced as that observed with KN62. Such results
could not be attributed to differences in inhibitors affinity, as
similar Ki values have been reported for both inhibitors to all
CaM kinases studied (Hidaka and Yokokura, 1996). However,
the idea that KN93 is unable to enter the sperm tail efficiently
cannot be discarded.
By immunological and biochemical studies, we were able to
detect the presence of active CaMKIV in the flagellum of
human sperm. In previous studies, CaMKIV was found in
mouse spermatids, where it is localized to the nucleus, and
participates in chromatin remodelling (Wu and Means, 2000).
Interestingly, changes in the subcellular localization of
CaMKIV (translocation from the nucleus into the cytoplasm)
have been described when granulosa cells differentiate into
luteinized cells (Wu et al., 2000b). Although there is no direct
evidence of CaMKIV translocation in the male gamete, the
existence of similar mechanisms during cellular differentiation
could explain the localization of CaMKIV in the flagellum of
mature sperm. Localization of CaMKIV in the sperm tail is
consistent with the role proposed for this enzyme in human
sperm motility regulation. In addition to CaMKIV,
immunodetection of CaMKII was attempted in whole cells and
in protein sperm extracts. Although efforts to find this enzyme
in human sperm were not successful, the presence of CaMKII
as well as CaMKI in these cells cannot be completely discarded.
Mammalian sperm motility is regulated by the
phosphorylated status of flagellar proteins (Carrera et al., 1996;
Si, 1999; Tash and Bracho, 1994; Vijayaraghavan et al., 1997).
Several lines of evidence have shown that Ca2+ participates in
the regulation of protein phosphorylation on tyrosine residues
(Visconti and Kopf, 1998). In human cells, it has been proposed
that Ca2+ reduces the level of protein tyrosine phosphorylation
through the activation of calcineurin, a CaM-dependent
serine/threonine phosphatase (Carrera et al., 1996) or by
decreasing intracellular ATP availability (Baker et al., 2004).
Moreover, participation of CaM in the signalling events leading
to protein tyrosine phosphorylation has been described in
mouse gametes (Zeng and Tulsiani, 2003). The effect of CaM
antagonists on tyrosine phosphorylation are probably related to
other CaM target enzymes, which are different to CaM kinases,
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Fig. 7. CaM kinase IV activity in human sperm. CaMKIV activity
was measured in sperm treated immediately after resuspension in the
Ca2+-containing medium (T0) or in sperm incubated in the same
medium for 18 hours in the absence (T18) or presence of 60 µM
KN62 [T18 (KN62)]. Sperm subjected to these different
experimental conditions were washed twice with PBS, cell
concentration was adjusted to 107 cells/ml, and aliquots were stored
at –20°C until use. Enzyme activity was measured in these extracts
using peptide gamma and [γ-32P]ATP as substrates. The results are
expressed as mean±s.e.m., n=7. *P<0.001 compared to CaMKIV
activity in T0 and T18 (KN62) cells; **P<0.01 compared to
CaMKIV activity in T0 and T18 cells.
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because either KN62 or KN93 do not modify tyrosine
phosphorylation pattern of human sperm. The findings from
these studies also suggest that CaM kinases are involved in
sperm motility by modulating intracellular pathways not
related with the regulation of tyrosine phosphorylation.
In addition to Ca2+ signalling, the cAMP/PKA pathway
plays a key role in the regulation of mammalian sperm motility
and protein tyrosine phosphorylation (Luconi and Baldi, 2003;
Turner, 2003). In the present study, the relationship between
CaM kinases and cAMP-activated events was analysed by
incubating human sperm with a CaM kinase inhibitor in the
presence of agonists of cAMP/PKA pathway. Such compounds
were unable to overcome KN62-mediated inhibition of sperm
motility. These results agree with previous findings in the
mouse that show that exogenous cAMP analogues could not
reverse motility inhibition caused by CaM antagonists (Si and
Olds-Clarke, 2000), suggesting that CaM and CaM kinase
regulation of flagellar movement is independent or downstream
of cAMP. Consistent with the independence of these two
pathways in the regulation of mammalian sperm motility, it
was recently demonstrated in bull gametes that although
induction of hyperactivation depends on the presence of Ca2+,
it does not require the activation of the cAMP/PKA pathway
(Marquez and Suarez, 2004). Similarly, in human sperm, Ca2+
is required for the development of hyperactivated motility
(Marin-Briggiler et al., 2003). However, in this study, we did
not find specific effects of CaM kinase inhibitors on
hyperactivated parameters. Although there is a reduction in
hyperactivation when human sperm are incubated in the
presence of KN62, this reduction is also observed in the
presence of KN04, the inactive KN62 analogue, suggesting
that this effect is not related to the inactivation of CaM kinases. 
This work provides evidence suggesting that members of the
CaM kinase family are involved in the Ca2+ regulation of
human sperm motility; however, the mechanism by which
these kinases are involved in this regulation is not clear. One
possibility is that the maintenance of energy levels is dependent
on CaM kinase regulation. In this respect, human sperm
incubated in media not supplemented with Ca2+ ions showed a
significant reduction in ATP levels. This decrease was also
observed in the presence of KN62 but not in the presence of
KN04 suggesting the involvement of CaM kinases in the
regulation of ATP metabolism. At what level this is controlled
is not known, and it is possible that CaM kinases are involved
in the regulation of the sperm glycolytic pathway. Further
studies are needed to understand the molecular mechanisms by
which CaM kinases regulate sperm motility and to clarify the
relationship between this and other previously reported
pathways.
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